Encompass Health Stock (NYSE:EHC)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$103.35

52W Range

$92.77 - $127.99

50D Avg

$104.41

200D Avg

$110.09

Market Cap

$10.16B

Avg Vol (3M)

$916.01K

Beta

0.59

Div Yield

$0.76 (0.72%)

EHC Company Profile


Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

28,572

IPO Date

Sep 24, 1986

Website

EHC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 21
Inpatient$5.76B$5.23B-
Other$178.90M--
Outpatient and Other-$142.70M-
Inpatient Rehabilitation Segment--$23.10M
Home Health and Hospice Segment--$300.00K

Fiscal year ends in Dec 25 | Currency in USD

EHC Financial Summary


Dec 25Dec 24Dec 23
Revenue$5.94B$5.37B$4.80B
Operating Income$1.05B$864.50M$1.72B
Net Income$566.20M$455.70M$352.00M
EBITDA$1.38B$1.19B$1.01B
Basic EPS$5.63$4.53$3.54
Diluted EPS$5.55$4.46$3.47

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 01, 26 | 12:00 AM
Q4 25Feb 06, 26 | 10:00 AM
Q3 25Oct 30, 25 | 10:00 AM

Peer Comparison


TickerCompany
FMSFresenius Medical Care AG & Co. KGaA
ICLRICON Public Limited Company
DVADaVita Inc.
CHEChemed Corporation
UHSUniversal Health Services, Inc.
RDYDr. Reddy's Laboratories Limited
ALGNAlign Technology, Inc.
SOLVSolventum Corporation
ELANElanco Animal Health Incorporated
ENSGThe Ensign Group, Inc.